dr. Julie Morscio

Journal Article
A1
open access

Depletion of the RNA binding protein QKI and circular RNA dysregulation in T-cell acute lymphoblastic leukemia

Alessia Buratin, Bruno Palhais (UGent) , Enrico Gaffo, Juliette Roels (UGent) , Julie Morscio (UGent) , Jolien Van Laere (UGent) , Silvia Orsi, Geertruij Te Kronnie, Pieter Van Vlierberghe (UGent) , Panagiotis Ntziachristos (UGent) , et al.

(2025) HAEMATOLOGICA. 110(4). p.972-979

Add to list

Journal Article
A1
open access

Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice

Tim Pieters (UGent) , Sara T'Sas (UGent) , Stijn Vanhee (UGent) , André Pedro Pinto De Almeida (UGent) , Yasmine Driege (UGent) , Juliette Roels (UGent) , Wouter Van Loocke (UGent) , Willem Daneels (UGent) , Mathijs Baens, Arnaud Marchand, et al.

(2021) JOURNAL OF EXPERIMENTAL MEDICINE. 218(10).

Add to list

The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL

Alessandra Di Grande, Sofie Peirs (UGent) , Paul D. Donovan, Maaike Van Trimpont (UGent) , Julie Morscio (UGent) , Béatrice Lintermans (UGent) , Lindy Reunes (UGent) , Niels Vandamme (UGent) , Steven Goossens (UGent) , Hien Anh Nguyen, et al.

(2021) BLOOD ADVANCES. 5(7). p.1963-1976

Add to list

Miscellaneous

Chemotherapy at the wheel of ALL relapse

Julie Morscio (UGent) and Pieter Van Vlierberghe (UGent)

(2020) BLOOD. 135(1). p.3-5

Add to list

Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma

Renate De Smedt (UGent) , Julie Morscio (UGent) , Lindy Reunes (UGent) , Juliette Roels (UGent) , Valentina Bardelli, Béatrice Lintermans (UGent) , Wouter Van Loocke (UGent) , Afonso Almeida, Laurence C. Cheung, Rishi S. Kotecha, et al.

(2020) BLOOD. 135(19). p.1685-1695

Add to list

Targeting steroid resistance in T-cell acute lymphoblastic leukemia

Renate De Smedt (UGent) , Julie Morscio (UGent) , Steven Goossens (UGent) and Pieter Van Vlierberghe (UGent)

(2019) BLOOD REVIEWS. 38.

Add to list

Journal Article
A1
open access

Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma

Renate De Smedt (UGent) , Sofie Peirs (UGent) , Julie Morscio (UGent) , Filip Matthijssens (UGent) , Juliette Roels (UGent) , Lindy Reunes (UGent) , Béatrice Lintermans (UGent) , Steven Goossens (UGent) , Tim Lammens (UGent) , Nadine Van Roy (UGent) , et al.

(2018) HAEMATOLOGICA. 104(1). p.e17-e20

Academic Bibliography

dr. Julie Morscio

Depletion of the RNA binding protein QKI and circular RNA dysregulation in T-cell acute lymphoblastic leukemia

Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice

The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL

Chemotherapy at the wheel of ALL relapse

Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma

Targeting steroid resistance in T-cell acute lymphoblastic leukemia

Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma

Contents

Support

Contact